Bayer sells HC Starck unit for 1.2 bln euros
501320
German chemicals and pharmaceuticals giant Bayer said that it has agreed to sell its metals subsidiary HC Starck to private equity firms Advent and Carlyle for about 1.2 billion euros (1.6 billion dollars) in total.
551896
Shareholders of German drug maker Bayer AG approved plans Wednesday to spin off chemicals and polymers business Lanxess, clearing the way for its listing on the stock market early next year.
281314
Bayer AG, the German drug and chemical company, has agreed to sell its plasma products business for $590 million in cash and stock to the private U.S. investment groups Cerberus Capital Management and Ampersand ...
2932
According to fdi.gov.cn: According to Germany-based Bayer Group, it has laid down a latest investment plan for 2009 in China. The plan will enable 1.8 billion euro of additional investment in Bayer's new synthetic material production project in Shanghai.
687968
German drug and chemical maker Bayer AG said Thursday it posted a third-quarter net profit of 34 million euros ($42.2 million), reversing losses from a year ago as a recovery in the chemical industry helped ...
348152
The German drug maker Bayer said its third-quarter profit fell 35 percent on costs related to its acquisition of a rival, Schering, but its performance still exceeded analystsÂ expectations. Bayer earned 320 million euros ($419 million) in the three months through September, down from 493 million euros a year earlier. Sales rose 26 percent, to 7.78 billion euros ($10.2 billion). The company, based in Leverkusen, said it booked special charges totaling 139 million euros ($182 million) in the quarter, with 106 million euros ($139 million) of that mostly attributable to the integration of its health care unit with Schering. Bayer bought Schering in June in a deal worth nearly 16.9 billion euros ($22 billion) to strengthen its health care business. The company said its health care unit was Âthe principal growth engine for BayerÂs business in the third quarter,Â with sales climbing 73 percent, to 3.48 billion euros ($4.56 billion).
717798
German drugs and chemicals group  Merck KGaA sold its worldwide electronic chemicals business to  BASF for 270 million euros ($352 million), the two companies  said on Friday.
503451
Lanxess AG, the spun-off chemicals and polymers business of German drug maker Bayer AG, made its debut on the Frankfurt stock exchange today.
691450
BERLIN -- German chemical and drug maker Bayer AG and New Jersey pharmaceutical company Schering-Plough Corp. announced Monday they have entered a strategic alliance under which Schering-Plough will distribute
63189
Bayer forged an alliance for its struggling pharmaceuticals business with American drug manufacturer Schering-Plough yesterday, cutting costs and marking another step in the German company&#39;s transformation.
727395
ROME  - Tiscali SpA, Europe's second-largest Internet service provider, said Monday it has sold its Austrian unit for nearly &#36;15 million US.
170214
BERLIN - Bayer AG, the German drug and chemical company, has agreed to sell its plasma products business for $590 million in cash and stock to the private US investment groups Cerberus Capital Management and Ampersand Ventures.
142333
German chemicals and pharmaceuticals giant Bayer said it had acquired the marketing rights for GlaxoSmithKline's erectile dysfunction treatment Levitra in a number of countries outside the US for 208 million euros (272 million dollars).
583185
Consolidation in Europe's drugs  sector gathered steam on Thursday as Germany's Merck unveiled a  $13.3-billion deal to buy Europe's top biotech firm Serono, and  Denmark's Nycomed won the drugs unit of Altana.
303789
Schering-Plough and Bayer have announced an agreement under which New Jersey-based Schering will attain US marketing rights to Bayer HealthCareâs primary care pharmaceutical products, including the antibiotics Avelox (moxifloxacin HCL) and Cipro
570313
German heavy industry giant Thyssenkrupp said it has sold residential property worth 2.1 billion euros (2.8 billion dollars) to a consortium comprising the real estate funds of Morgan Stanley and German group ...
335250
VNU, the Dutch market research and information group, yesterday sold its directories business for â¬2.1bn (Â£1.4bn) to venture capital groups Apax Partners and Cinven.